Page 184 - 2026 SMOG
P. 184

VASOPRESSOR PRIORITY CHART
              Hypovolemic    Septic    Cardiogenic   Neurogenic   Burn
                 Shock       Shock       Shock       Shock       Shock
          1°  Vasopressors are   Norepinephrine  Norepinephrine  Norepinephrine  Vasopressin
             not recommended
             in the initial
             stabilization of
             hypovolemic
             shock
          2°  Norepinephrine  Epinephrine   Dobutamine 5  Vasopressin   Norepinephrine
                          (add-on)                (add-on)
          3°  Vasopressin   Phenylephrine  Epinephrine  Epinephrine  Epinephrine
             (add-on)
         •  Vasopressors should only be initiated with/after adequate resuscitation is provided with
           crystalloids, colloids, and/or blood products.
         •  Maintain mean arterial pressure (MAP) 65mmHg or as needed to achieve adequate endorgan
           perfusion (e.g., cerebral perfusion pressure, abdominal perfusion pressure, urinary output).
         1. Norepinephrine: Vasopressor of choice in septic, cardiogenic, and hypovolemic shock.
         2. Epinephrine: Vasopressor of choice for Anaphylactic Shock. Used as an add-on agent to
           norepinephrine in septic shock when an additional agent is required to raise MAP to target and
           occasionally as an alternative first-line agent if norepinephrine is contraindicated.
         3. Vasopressin: Add-on to norepinephrine to raise blood pressure to target MAP or decrease
           norepinephrine requirement. Not recommended as a replacement for a first-line vasopressor.
         4. Phenylephrine: Alternative vasopressor for patients with septic shock who: (1) develop
             tachyarrhythmias on norepinephrine, epinephrine, or dopamine, (2) have persistent shock
           despite use of two or more vasopressor/inotropic agents including vasopressin (salvage
           therapy), or (3) have high cardiac output with persistent hypotension.
         5. Dobutamine: Initial agent of choice in cardiogenic shock with low cardiac output and
           maintained blood pressure. Add-on to norepinephrine for cardiac output augmentation in
           septic shock with myocardial dysfunction (e.g., in elevated left ventricular filling pressures and
           adequate MAP) or ongoing hypoperfusion despite adequate intravascular volume and use of
           vasopressor agents.
         6. Due to the physiologic nature of Neurogenic Shock, vasopressors may be initiated earlier to
           avoid volume overload.















        176  •   MEDICATIONS
   179   180   181   182   183   184   185   186   187   188   189